Testing Centers

Screen. Test. Treat.® 

#1 Ancillary for over 800 medical clinics in the U.S. since 2010

Diabetes Testing Centers (2-Minute Explainer Video)

What are Diabetes Testing Centers?

Diabetes Testing Centers™ (DTC) are a Medicare-reimbursable medical ancillary services company that provides integrative products and services for diabetes, prediabetes, and insulin-resistant patients. 

Our company is the undisputed leader in providing comprehensive multispecialty assessments that can be administered in medical clinics across the U.S. Our products have been the #1 ancillary for over 800 medical clinics since 2010, and we continue to dominate the market. Our business model offers unparalleled flexibility, from individual products to fully staffed medical clinics. Our DM-Flow/Trio package is a game-changer, with three (3) highly reimbursable tests to help medical providers reduce risks and increase practice revenue. 

(Click here for more information)

NEW! Try Before You Buy

Investing in new equipment technology can be vital to staying competitive and efficient if you're a clinic owner or manager. Some of our proprietary medical equipment is available for rent, allowing you to get familiar with its capabilities without committing to a purchase. For example, renting our Diabetic Neuropathy Device is available for only $499-monthly with unlimited testing. Renting our medical equipment can elevate your clinic's capabilities and take your medical practice to the next level. Call us for pricing on other items, and see the significant difference for yourself with our medical equipment today!

(Click here for more information)

Over 60% of Costs Paid by Medicare Are for People Living with Diabetes

Am Diabetes Assoc. Economic Costs of Diabetes in the US in 2017. Diabetes Care. 2018;41:917–928.

Prioritizing the prevention of morbidity and mortality risks with our goal.  Managing the costs associated with diabetes is a significant concern for Medicare, and using non-invasive testing devices can effectively address this issue. Prioritizing preventive measures and condition management is crucial for individuals with diabetes, and taking these steps can help reduce the need for costly interventions. Focusing on prevention and early intervention can help improve outcomes for those living with diabetes and reduce the overall burden on the healthcare system.

Unlock the power of Medicare reimbursement with our evidence-based assessments while maximizing your practice's financial potential.

Step 1: Screen

Screening for diabetes, prediabetes, and diagnosis with 5-min results for A1C.

Screen 45+ years for A1c or if <45, are overweight (BMI 25+), and have 1+ risk factors for prediabetes (A1c 5.7+).

⭐️ ⭐️ ⭐️⭐️ ⭐️  Simply simple. -Jay Fluham FNP-C, Primary Care

Step 2: Test

Utilizing evidence-based technology in diabetes management. 

The only multifunctional tool with two (2) reimbursable neuropathies for large and small fiber neuropathy.

⭐️ ⭐️ ⭐️ ⭐️ ⭐️ The DND replaces tuning forks and monofilaments. -K. Suzuki DPM

Step 3: Treat

Therapeutic treatments that do not use pharmaceuticals.

A patented Insulin Sensitivity Supplement is scientifically formulated to support metabolic and cardiovascular systems.

⭐️ ⭐️ ⭐️ It is inspiring, motivating, and brings hope! -C. Ortega MD FACEP


Evidence-Based Reductions

Our assessments and therapies are evidence-based. The diabetes center is expertly designed to cater specifically to the needs of individuals living with diabetes. The center's development is rooted in the national guidelines set forth by prominent organizations focused on prevention, guaranteeing that it provides effective and indispensable solutions for managing diabetes. By prioritizing the needs of those living with diabetes, the center delivers superior care and support to those who require it. 

Studies have demonstrated that implementing evidence-based technology can be a valuable tool in minimizing the risk of complications associated with diabetes.; blindness (-95%), heart disease (-68%), stroke (-53%),  amputations (-51%), and kidney failure (-28%). 

Screen. Test. Treat.

Our non-invasive tests are fast. Our non-invasive tests are designed to be quick and efficient, taking no more than 3-5 minutes each to complete. We aim to provide patients with comprehensive education, support, and resources to help them manage their diabetes and improve their quality of life. Our tools are available in various bundled or à la carte options, allowing clinics to choose the HEDIS gap, test, or therapy that best meets their needs for diabetic patients. This way, organizations can tailor their approach and ensure that each patient receives the most effective and appropriate care possible.


Increase Reputation

Better Patient Outcomes

At Diabetes Testing Centers™ (DTC), we provide clinics with a practical solution to help them manage diabetes and its related health complications. Our exclusive assessments can reduce their patient load and generate greater revenue. We partner with over 800 primary care clinics to expand their 'Continuity of Care' connections with diabetic patients. Our tools are straightforward, evidence-based, and reimbursable, making it possible to have a swift and meaningful impact on diabetes outcomes. We believe that primary care and multispecialty clinics are pivotal in managing diabetes and are proud to support them.

Our products and services help clinics generate more revenue with fewer patients. For instance, clinics managing diabetes patients can generate the same revenue as forty (40) non-diabetic patients by only seeing ten (10) patients daily. By screening adults with a BMI of 25+ or an A1c of 5.7+, clinics can better manage their diabetic patients while seeing fewer patients and potentially double their revenue.

Ten(10) DM Patients = Twenty (40) Standard Patients

Click on our programs below to learn more...

Diabetic Neuropathy (Painful/Painless)

Diabetic Neuropathy Device (DND)

Do you still use old tools like the tuning fork and monofilament for foot exams? See the images below.

Free or Reimbursable Exams?

It is imperative that medical providers thoroughly research reimbursement policies for both small-fiber and large-fiber tests when conducting foot exams. These tests have been eligible for reimbursement by Medicare since 2010, and it is essential to note that traditional diagnostic tools produce subjective results when testing for mobility issues and Loss of Protective Sensation (LOPS), which can ultimately lead to amputations. Therefore, employing modern objective tools for a more precise diagnosis with reimbursements is highly recommended.

(Painful) Small Fiber Neuropathy Can Only be Verified with Thermal Thresholds or Skin Biopsies.

Aaron Vinik, MD, Ph.D., Endocrinologist, Diabetic Neuropathies, February 5, 2018

Diabetic neuropathy (DN) is challenging to diagnose due to the lack of standardized methods. Early intervention is crucial as painful DN can be difficult to manage without treatment. A failed monofilament test indicates severe neuropathy, emphasizing the need for objective diagnosis and timely referrals.

(Painless) Diabetic Large Nerve Fiber Dysfunction, as Measured by Vibration, Predicts Foot Ulceration, Amputation, and Mortality.


Early screening, recognition, and tailored treatment are crucial for diabetic neuropathy. The Diabetic Neuropathy Device™ offers objective measurements of nerve fibers for targeted therapies, promoting uniformity in foot care programs across medical institutions.

Up to 85% of Lower Extremity Amputations Among Persons with Diabetes Can be Prevented with Improved Foot Care Programs.

 Bild DE, et al. Lower Extremity Amputations in People with Diabetes: Epidemiology and Prevention. Diabetes Care 1989; 12:24-31; CDC MMWR November 01, 1991 / 40(43);737-739

Modern vs Outdated

It is recommended to use a multifunctional tool with thermal thresholds to measure (small fibers) and variable vibrations to measure (large fibers).

DN Accounts for More Hospitalizations than All Other Diabetes Complications Combined...

Aaron Vinik, MD, Ph.D., Endocrinologist, Diabetic Neuropathies, February 5, 2018

Schedule a Meeting